BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2905061)

  • 1. Inhibition of gastric acid secretion by peptide YY is independent of gastric somatostatin release in the rat.
    Greeley GH; Guo YS; Gomez G; Lluis F; Singh P; Thompson JC
    Proc Soc Exp Biol Med; 1988 Dec; 189(3):325-8. PubMed ID: 2905061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of peptide YY on gastric acid secretion, gastrin and somatostatin release in the rat.
    Eissele R; Koop H; Arnold R
    Z Gastroenterol; 1990 Mar; 28(3):129-31. PubMed ID: 1971469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones.
    Guo YS; Singh P; Gomez G; Greeley GH; Thompson JC
    Gastroenterology; 1987 May; 92(5 Pt 1):1202-8. PubMed ID: 3557015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of peptide YY on gastric acid output in rats.
    Hashimoto Y; Sano I; Nagahata Y; Wang ZT; Itoh A; Takeda K; Ichihara T; Moritomo H; Urakawa T; Saitoh Y
    Scand J Gastroenterol Suppl; 1989; 162():134-7. PubMed ID: 2595285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbutaline, a beta 2-adrenoreceptor agonist, inhibits gastric acid secretion and stimulates release of peptide YY and gastric inhibitory polypeptide in dogs.
    Kogire M; Izukura M; Gomez G; Uchida T; Greeley GH; Thompson JC
    Dig Dis Sci; 1990 Apr; 35(4):453-7. PubMed ID: 2156661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal and peripheral modulation of gastric acid secretion and arterial pressure by neuropeptide Y, peptide YY, and pancreatic polypeptide in rats.
    Wager-Pagé SA; Rosenbaum G; Veale WL; Davison JS
    Peptides; 1993; 14(6):1299-308. PubMed ID: 8134313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory action of peptide YY on gastric acid secretion.
    Guo YS; Fujimura M; Lluis F; Tsong Y; Greeley GH; Thompson JC
    Am J Physiol; 1987 Sep; 253(3 Pt 1):G298-302. PubMed ID: 2888314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man.
    Wettergren A; Maina P; Boesby S; Holst JJ
    Scand J Gastroenterol; 1997 Jun; 32(6):552-5. PubMed ID: 9200286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
    Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
    Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide YY inhibits gastric acid secretion stimulated by the autonomic nervous system.
    Clave P; Lluis F; Thompson JC; Greeley GH
    Biol Signals; 1992; 1(1):40-5. PubMed ID: 1364034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterogastrone-like effect of peptide YY is vagally mediated in the dog.
    Pappas TN; Debas HT; Taylor IL
    J Clin Invest; 1986 Jan; 77(1):49-53. PubMed ID: 2868024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide YY interacts with secretin and duodenal acidification to inhibit gastric acid secretion.
    Lluis F; Gomez G; Fujimura M; Greeley GH; Townsend CM; Thompson JC
    Regul Pept; 1987 Aug; 18(3-4):155-63. PubMed ID: 3671783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of peptide YY on gastric acid output in rats].
    Hashimoto Y; Nagahata Y; Urakawa T; Saitoh Y
    Nihon Shokakibyo Gakkai Zasshi; 1992 Jan; 89(1):1-8. PubMed ID: 1560592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of various gastrointestinal peptides on gastric somatostatin release.
    Chiba T; Taminato T; Kadowaki S; Inoue Y; Mori K; Seino Y; Abe H; Chihara K; Matsukura S; Fujita T; Goto Y
    Endocrinology; 1980 Jan; 106(1):145-9. PubMed ID: 7349951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin antibody does not influence bombesin-induced inhibition of gastric acid secretion in rats.
    Martínez V; Yang H; Wong HC; Walsh JH; Taché Y
    Peptides; 1995; 16(1):1-6. PubMed ID: 7716060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin and oxyntomodulin-(30-37) potentiate PYY regulation of gastric acid and somatostatin secretions.
    Bado A; Cloarec D; Moizo L; Laigneau JP; Bataille D; Lewin MJ
    Am J Physiol; 1993 Jul; 265(1 Pt 1):G113-7. PubMed ID: 8101697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal injection of bombesin inhibits gastric acid secretion in the rat.
    Yang H; Cuttitta F; Raybould H; Taché Y
    Gastroenterology; 1989 Jun; 96(6):1403-9. PubMed ID: 2714571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements of peptide YY for biological activity at enteric sites.
    Yoshinaga K; Mochizuki T; Yanaihara N; Oshima K; Izukura M; Kogire M; Sumi S; Gomez G; Uchida T; Thompson JC
    Am J Physiol; 1992 Nov; 263(5 Pt 1):G695-701. PubMed ID: 1443144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anesthetic dependence of the inhibitory effect of neurotensin on pentagastrin-stimulated acid secretion in rats. A possible role for somatostatin.
    Hammer RA; Fernandez C; Ertan A; Arimura A
    Life Sci; 1991; 48(4):333-9. PubMed ID: 1671292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracisternal injection of peptide YY inhibits gastric emptying in rats.
    Chen CH; Rogers RC; Stephens RL
    Regul Pept; 1996 Feb; 61(2):95-8. PubMed ID: 8852810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.